|
GPC Biotech (also referred to as GPCbiotech and GPC-Biotech) is a German biopharmaceutical company. The company's mission statement reads "... to discover, develop and commercialize new anticancer drugs."[1] Literally a public company is a company owned by the public. ...
1997 is a common year starting on Wednesday of the Gregorian calendar. ...
A suburb of Munich, Germany, about 15 km south-west from the city center. ...
Chief Executive Officer (CEO) is the job of having the ultimate executive responsibility or authority within an organization or corporation. ...
CFO is usually short for Chief Financial Officer, but may also mean: Carrier frequency offset Ceramic fiber optics Chief Fire Officer Chief of Flight Operations Conselho Federal de Odontologia (cfo. ...
Biotechnology is technology based on biology, especially when used in agriculture, food science, and medicine. ...
In business, revenue is the amount of money that a company actually receives from its activities, mostly from sales of products and/or services to customers. ...
The front page of the English Wikipedia website. ...
Biopharmaceuticals are medical drugs (see pharmacology) produced by biotechnology. ...
Founded in 1997, the company was held privately until May 2000 when an initial public offering was made on the now defunct German Neuer Markt. Subsequent to the closing of the Neuer, GPC refinanced in June 2004 through a public stock offering and listed American Depositary Receipts on the United States NASDAQ exchange. 2000 is a leap year starting on Saturday of the Gregorian calendar. ...
2004 is a leap year starting on Thursday of the Gregorian calendar. ...
An American Depositary Receipt (ADR) is how the stock of most foreign companies trades in United States stock markets. ...
NASDAQ MarketSite (Times Square, New York City) at night NASDAQ (originally an acronym for National Association of Securities Dealers Automated Quotations) is an American electronic stock exchange. ...
In March 2000, the company acquired Mitotix, a United States biotechnology firm located in Cambridge, Massachusetts. This acquisition has led to the company having ~50% of it's employees based in the United States and the remaining 50% in Germany. Further, the acquisition of Mitotix provided convenient proximity to GPC's long term and continuing collaboration with ALTANA Pharma AG and the ALTANA Research Institute, located in Waltham, Massachusetts. 2000 is a leap year starting on Saturday of the Gregorian calendar. ...
Harvard Square, May 2000 Cambridge is a city in the Greater Boston area of Massachusetts, United States. ...
Waltham is a city located in Middlesex County, Massachusetts. ...
Products
As of July 2005, the company does not have a marketed product, though it has three therapeutics in its drug discovery pipeline as shown in the table below. In medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are discovered and/or designed. ...
In medicine, a clinical trial (synonyms: clinical studies, research protocols, medical research) is a research study. ...
Monoclonal antibodies (mAb) are antibodies that are identical because they were produced by one type of immune cell, all clones of a single parent cell. ...
In medicine, a clinical trial (synonyms: clinical studies, research protocols, medical research) is a research study. ...
Lymphoma is a general term for localized malignancies that develop in the lymphatic or reticuloendothelial system. ...
Activities that need to be performed and results to be obtained a before a clinical trial in humans can begin. ...
When normal cells are damaged or old they undergo apoptosis; cancer cells, however, avoid apoptosis. ...
Notes - ^ Mission statement obtained from http://www.gpc-biotech.com/en/about_the_company/index.html. Retrieved July 9, 2005.
- A portion of basic corporate information was obtained from the Hoover's Online Fact Sheet for GPC Biotech AG. Retrieved July 9, 2005.
- reference: Annual Report for the year 2000. Retrieved July 11, 2005.
- reference: Annual Report for the year 2004. Retrieved July 11, 2005.
|